Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 276,741 | 240,251 | 231,808 | 99,802 | 87,069 |
| Cost of Goods | 149,476 | 138,295 | 133,704 | 56,046 | 46,355 |
| Gross Profit | 127,265 | 101,956 | 98,104 | 43,756 | 40,714 |
| Operating Expenses | 117,701 | 99,349 | 96,653 | 49,437 | 38,851 |
| Operating Income | 10,040 | 2,902 | 2,155 | -5,635 | 2,218 |
| Interest Expense | 6,230 | 5,540 | 9,998 | 854 | 985 |
| Other Income | 14 | -12 | 0 | 2,000 | 56 |
| Pre-tax Income | 3,824 | -2,650 | -7,843 | -4,489 | 1,289 |
| Income Tax | 1,184 | -2,254 | -1,701 | -1,954 | 157 |
| Net Income Continuous | 2,640 | -396 | -6,142 | -2,535 | 1,132 |
| Net Income | $2,640 | $-396 | $-6,142 | $-2,535 | $1,132 |
| EPS Basic Total Ops | 0.07 | -0.14 | -0.40 | -0.04 | 0.02 |
| EPS Basic Continuous Ops | 0.03 | -0.01 | -0.08 | -0.04 | 0.02 |
| EPS Diluted Total Ops | 0.07 | -0.14 | -0.40 | -0.04 | 0.02 |
| EPS Diluted Continuous Ops | 0.03 | -0.01 | -0.08 | -0.04 | 0.02 |
| EPS Diluted Before Non-Recurring Items | 0.13 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $32,314 | $25,933 | $28,861 | $1,507 | $7,924 |